hydration effects glp-1 receptor agonists weight loss 2025 Agonist Market Size, Share, Growth, 2034 Managing Side Effects of GLP-1
Description
FDAs concerns with unapproved GLP-1 drugs used for weight loss (2025)

Weiss T, Yang L, Carr RD, Pal S, Sawhney B, Boggs R, et al

A new study reports that using semaglutide is not associated with an increased risk for eye disorders or diabetic retinopathy

Q: When might Points be helpful

See Figure 1

R.Badve sunilv.JunM.JardineM
